Cronos Group (STU:7CI) Tariff Resilience Score: 6/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:7CI Cronos Group Inc STU:7CI
85 GF Score
Price €2.42
GF Value €3.09
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Cronos Group Tariff Resilience Score?

Cronos Group STU:7CI +0.50% 85 Tariff Resilience Score is 6 as of Jul. 14, 2026. GuruFocus rates STU:7CI with a GF Score™ of 85/100 and a GF Value™ of €3.09 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,029 Drug Manufacturers companies, Cronos Group ranks better than 91.06% on this metric.

Cronos Group has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Cronos Group has Cronos has some exposure due to its international cannabis operations. However, its diversified supply chain and focus on local markets mitigate significant tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Cronos Group might have Average Resilient.

Cronos Group  (STU:7CI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Cronos Group Tariff Resilience Score Related Terms

STU:7CI vs ZTS, UTHR: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cronos Group Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cronos Group's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Cronos Group's Tariff Resilience Score falls into.


STU:7CI
85GF Score
Cronos Group Inc STU:7CI
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Cronos Group (STU:7CI) has a Tariff Resilience Score of 6 as of Jul. 14, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Cronos Group ranks #92 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 8.9%.
Is Cronos Group's Tariff Resilience Score too high?
Cronos Group's current Tariff Resilience Score is 6. Based on the distribution chart, Cronos Group ranks #92 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cronos Group has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cronos Group's Tariff Resilience Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cronos Group ranks #92 out of 1029 companies for Tariff Resilience Score. This places Cronos Group in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Cronos Group's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cronos Group stock overvalued right now?
Based on GuruFocus' analysis, Cronos Group (STU:7CI) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.09, compared to a current price of €2.42 — trading 21.8% below its estimated fair value. The current Tariff Resilience Score is 6. Cronos Group's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Cronos Group (STU:7CI), the current Tariff Resilience Score is 6 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cronos Group (STU:7CI) Overvalued in 2026?

Based on GuruFocus' analysis, Cronos Group stock appears to be undervalued. The current stock price of €2.42 is trading 21.8% below its estimated GF Value™ of €3.09. GuruFocus considers Cronos Group to be Modestly Undervalued.

Key valuation signals for STU:7CI:

  • Tariff Resilience Score: 6
  • GF Value™: €3.09 vs. price of €2.42 (21.8% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the STU:7CI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cronos Group Business Description

Other Exchanges CRON:USACRON:Canada
Address 4491 Concession Rd 12, Stayner, ON, CAN, L0M 1S0
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
85GF Score

Get the complete analysis for STU:7CI

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.42
Price
€3.09
GF Value